Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 66.7% decrease from the number of companies cited in the previous year.
The citations in the county include:
- You administered a prohibited drug in an extralabel manner to food-producing animal(s).
- You offered food-producing animal(s) for interstate commerce that was found to bear or contain a drug residue in an edible tissue above an established safe level, safe concentration, or tolerance.
- You did not identify and segregate treated animals.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Larry Fryfogle | Veterinary | 06/07/2023 | Drugs prohibited for extralabel use in food-producing animal(s) |
Larry Fryfogle | Veterinary | 06/07/2023 | Introduction/delivery into IS - illegal drug residue |
Larry Fryfogle | Veterinary | 06/07/2023 | Control of treated animals |
Larry Fryfogle | Veterinary | 06/07/2023 | Drug inventory (control of drugs on premises) |
Larry Fryfogle | Veterinary | 06/07/2023 | Record keeping |
Larry Fryfogle | Veterinary | 06/07/2023 | Use of veterinary prescription drug(s) without a prescription |